Journal of Parkinsons Disease

Papers
(The TQCC of Journal of Parkinsons Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Acknowledgment to reviewers 2024126
New Journal Section: Hidden Gems from the Literature of Parkinson’s Disease117
Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson’s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Interven72
In Their Own Words: Fears Expressed by People with Parkinson’s Disease in an Online Symptom Database72
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension69
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson’s Disease67
Prospective Study of Lung Function with Prodromal, Clinical Parkinson’s Disease, and Mortality62
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness61
PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy54
Pain and the Non-Pharmacological Management of Pain in People with Parkinson’s Disease46
Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson’s Disease46
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention44
Considerations on How to Prevent Parkinson’s Disease Through Exercise43
The Importance of Digital Health Literacy in an Evolving Parkinson’s Disease Care System42
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression41
Clinical Trial Highlights: Modulators of Mitochondrial Function40
People with Parkinson’s as Partners for the Journal of Parkinson’s Disease39
Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease38
Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia36
The Placebo Response in Double-Blind Randomised Trials Evaluating Regenerative Therapies for Parkinson’s Disease: A Systematic Review and Meta-Analysis36
Cognition and Other Non-Motor Symptoms in an At-Risk Cohort for Parkinson’s Disease Defined by REM-Sleep Behavior Disorder and Hyposmia36
Altered Functional Connectivity of the Subthalamic Nucleus in Parkinson’s Disease: Focus on Candidates for Deep Brain Stimulation35
Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease35
Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson’s Disease34
Evaluation of Nocturnal Symptoms in Chinese Parkinson’s Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study33
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?32
Extra-Basal Ganglia Brain Structures Are Related to Motor Reserve in Parkinson’s Disease32
Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease32
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients32
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms32
Adherence to Non-Pharmacological Interventions in Parkinson’s Disease: A Rapid Evidence Assessment of the Literature31
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process31
The Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease on Associative Learning of Verbal and Non-Verbal Information by Trial and Error or with Corrective Feedback30
Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson’s Disease?30
Erratum to: CiteSerum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study30
Pilot Study Results Assessing the Accuracy of a Ballistic Sleep Monitor Relative to Polysomnography in Parkinson’s Disease30
Which Gait Tasks Produce Reliable Outcome Measures of Freezing of Gait in Parkinson’s Disease?30
Diabetes and Parkinson’s Disease: Understanding Shared Molecular Mechanisms29
Dietary Interventions in Parkinson’s Disease28
Reduced Prevalence of Parkinson’s Disease in Patients Prescribed Calcineurin Inhibitors28
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy28
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?28
Implicit Motor Sequence Learning in People with Mild to Moderate Parkinson’s Disease: Behavior and Related Brain Function27
The Promise of Mendelian Randomization in Parkinson’s Disease: Has the Smoke Cleared Yet for Smoking and Parkinson’s Disease Risk?27
Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study27
A New Era: The Growth of Video-Based Visits for Remote Management of Persons with Parkinson’s Disease27
Understanding the Role of CDH4 in Multiple System Atrophy Brain27
Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson’s Disease27
Falls Predict Acute Hospitalization in Parkinson’s Disease26
Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson’s Disease to the Clinic: The Investigator’s Perspective26
Alcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis25
Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex25
Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease25
Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease24
Telerehabilitation for Communication and Swallowing Disorders in Parkinson’s Disease24
Epidemiological Evidence for an Immune Component of Parkinson’s Disease24
Microglia in Parkinson’s Disease24
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease24
Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews24
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists24
How Time Rules: Diurnal Motor Patterns in de novo Parkinson’s Disease24
The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline23
Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson’s Disease?23
Effort-Based Decision-Making for Exercise in People with Parkinson’s Disease23
Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson’s Disease in a Chinese Cohort22
α-Synuclein Responses in the Laterodorsal Tegmentum, the Pedunculopontine Tegmentum, and the Substantia Nigra: Implications for Early Appearance of Sleep Disorders in Parkinson’s Disease22
Clinical and Genetic Analysis of Psychosis in Parkinson’s Disease22
Predicting Parkinson’s Disease and Its Pathology via Simple Clinical Variables21
Frequency and Characteristics of Psychosis in Parkinson’s Disease: A Systematic Review and Meta-Analysis21
Biomarkers of Cerebral Glucose Metabolism and Neurodegeneration in Parkinson’s Disease: A Cerebrospinal Fluid-Based Study20
Evidence-Based Aquatic Therapy Guidelines for Parkinson’s Disease: An International Consensus Study20
Boxing with and without Kicking Techniques for People with Parkinson’s Disease: An Explorative Pilot Randomized Controlled Trial20
Self-Perception of Voice and Swallowing Handicap in Parkinson’s Disease20
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits20
Inflammasome Activation in Parkinson’s Disease20
Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls18
The Dawning of a Brighter Future: Celebrating 10 Years of Journal of Parkinson’s Disease18
Body-First Subtype of Parkinson’s Disease with Probable REM-Sleep Behavior Disorder Is Associated with Non-Motor Dominant Phenotype18
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies18
Prevalence and Clinical Characteristics of Dementia and Cognitive Impairment in Multiple System Atrophy: A Systematic Review and Meta-Analysis17
The Cost of Gait Slowness: Can Persons with Parkinson’s Disease Save Energy by Walking Faster?17
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?17
Taking the Time to Assess Cognition in Parkinson’s Disease: The Clock Drawing Test17
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease17
Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies17
Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease Progression17
GDNF Therapy: Can We Make It Work?17
Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors17
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring16
Cannabis in Parkinson’s Disease: The Patients’ View16
Lack of Association of Locus Coeruleus Pathology with Orthostatic Hypotension in Parkinson’s Disease16
Presence of Skin α-Synuclein Deposits Discriminates Parkinson’s Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome16
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead15
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update15
From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease15
Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations15
Effects of Continuous Dopaminergic Stimulation on Parkinson’s Disease Gait: A Longitudinal Prospective Study with Levodopa Intestinal Gel Infusion15
Focused Ultrasound Thalamotomy in Tremor Dominant Parkinson’s Disease: Long-Term Results15
Non-motor symptoms in prodromal Parkinson's disease are linked to reduced quality of life15
Association of motor subtype and tremor type with Parkinson's disease progression: An exploratory longitudinal analysis15
New insights from a Malaysian real-world deep brain stimulation cohort14
Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson’s Disease14
Cost-Effectiveness Analyses of Non-Pharmacological and Non-Surgical Interventions in Idiopathic Parkinson’s Disease: A Systematic Review14
Urinary Tract Infection in Parkinson’s Disease14
Swallow Safety and Laryngeal Kinematics: A Comparison of Dysphagia Between Parkinson’s Disease and Cerebrovascular Accident14
Are Preformed Fibrils a Model of Parkinson’s Disease?14
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”14
A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson’s Disease: Getting it right, if not PARFECT14
Pointing in the right direction: Greater motor improvements with directional versus circular subthalamic nucleus deep brain stimulation for Parkinson's disease14
Autonomic and Depression Symptoms in Parkinson’s Disease: Clinical Evidence for Overlapping Physiology14
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?14
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy14
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis13
Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson’s Disease?13
Advice to People with Parkinson’s in My Clinic: Cannabis13
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease13
Self-Image in Women with Parkinson’s Disease13
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease13
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative13
A Retrospective Comparison of Multiple Approaches to Anatomically Informed Contact Selection in Subthalamic Deep Brain Stimulation for Parkinson’s Disease13
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease13
Prospective Role of PAK6 and 14-3-3γ as Biomarkers for Parkinson’s Disease13
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation13
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders13
Immunophenotyping Tracks Motor Progression in Parkinson’s Disease Associated with a TH Mutation12
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease12
Postmortem Cerebellar Volume Is Not Reduced in Essential Tremor: A Comparison with Multiple System Atrophy and Controls12
Experimental Animal Models of Prodromal Parkinson’s Disease12
What Patients Say: Large-Scale Analyses of Replies to the Parkinson’s Disease Patient Report of Problems (PD-PROP)12
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies12
Unmet Need in Early-Onset Parkinson’s Disease: Deep Brain Stimulation and Pregnancy12
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson’s Disease12
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort12
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease12
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease12
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease12
Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis12
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations12
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients12
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review12
Remote Sensing Data as a Tool for Studying Environmental Aspects of Parkinson’s Disease12
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson’s Disease12
Exploring the Connection Between the Gut Microbiome and Parkinson’s Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options11
Exploring the Complex Phenotypes of Impaired Finger Dexterity in Mild-to-moderate Stage Parkinson’s Disease: A Time-Series Analysis11
Astrocytes and Alpha-Synuclein: Friend or Foe?11
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders11
Cross-Cultural Differences in Stigma Associated with Parkinson’s Disease: A Systematic Review11
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative11
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease11
Autopallidotomy: From Colloquial Term to Scientific Theory11
Towards a Visualizable, De-identified Synthetic Biomarker of Human Movement Disorders11
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease11
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions11
Patient Empowerment for Those Living with Parkinson’s Disease11
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease11
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials11
Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants11
How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types11
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”11
Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts11
Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson’s Disease?10
Dual-Task Costs of Quantitative Gait Parameters While Walking and Turning in People with Parkinson’s Disease: Beyond Gait Speed10
Strengthening Communication and Collaboration in the Fragmented German Healthcare System: A Mixed-Method Evaluation of an Interdisciplinary Network for Parkinson’s Disease10
Driving and Parkinson’s Disease: A Survey of the Patient’s Perspective10
Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson’s Disease10
The Cause and Duration of Emergency Admissions to Hospital in People with Idiopathic Parkinson’s Disease, Under the Care of a UK Service, During the First Year of the COVID-19 Pandemic10
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study10
Determinants of Self-Stigma in People with Parkinson’s Disease: A Mixed Methods Scoping Review10
Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson’s Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis10
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group10
Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson’s Disease and Pink1 Knockout Rats10
Structural and Functional Correlates of Hallucinations and Illusions in Parkinson’s Disease10
Professionals’ Treatment Preferences in the Prodromal Phase of Parkinson’s Disease: A Discrete Choice Experiment10
A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies10
Post-Illumination Pupil Response as a Biomarker for Cognition in α-Synucleinopathies10
Prasinezumab and Cinpanemab – The Perspective of a Person with Parkinson’s10
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease10
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity10
Digital Health Technology to Measure Drug Efficacy in Clinical Trials for Parkinson’s Disease: A Regulatory Perspective10
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease10
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils10
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson’s Disease10
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort10
Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling10
Experienced Respiratory Symptoms and the Impact on Daily Life from the Perspective of People with Parkinson’s Disease: A Grounded Theory9
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson’s Disease (PSYCHO-STIM II)9
Effects of a Highly Challenging Balance Training Program on Motor Function and Brain Structure in Parkinson’s Disease9
Parkinson’s Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers9
Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease9
Subthalamic Stimulation for Camptocormia in Parkinson’s Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness9
Does Gut Microbiota Influence the Course of Parkinson’s Disease? A 3-Year Prospective Exploratory Study in de novo Patients9
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials9
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications9
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study9
Diabetes Mellitus and Parkinson’s Disease: A Systematic Review and Meta-Analyses9
Parkinson’s Disease and the COVID-19 Pandemic9
Development of a Multidimensional Assessment Tool for the Evaluation of Holistic Quality of Life in Parkinson’s Disease9
A Multisensory Deficit in the Perception of Pleasantness in Parkinson’s Disease9
Clinical Non-Motor Phenotyping of Black and Asian Minority Ethnic Compared to White Individuals with Parkinson’s Disease Living in the United Kingdom9
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update9
Association Between Thyroid Diseases and Parkinson’s Disease: A Nested Case-Control Study Using a National Health Screening Cohort9
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder9
Waiting for PARIS—A Biological Target in Search of a Drug9
The Home-Based Sleep Laboratory9
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder9
Different Alterations of Agonist and Antagonist Binding to 5-HT1A Receptor in a Rat Model of Parkinson’s Disease and Levodopa-Induced Dyskinesia: A MicroPET Study9
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review9
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease9
Digital Therapeutics in Parkinson’s Disease: Practical Applications and Future Potential9
Early Parkinson’s Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms9
The Effects of Deep Brain Stimulation in Patients with Multiple System Atrophy9
0.34701800346375